Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,440.45
23.5 (1.66%)
BSENSE

Aug 11

BSE+NSE Vol: 2.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryConcord Biotech VS Pharmaceuticals & Biotechnology
 
1D
1.66%
-0.51%
1W
1.35%
-0.36%
1M
10.46%
0.74%
YTD
7.06%
-8.3%
1Y
-10.17%
-3.05%
3Y
%
19.63%
5Y
%
43.32%
10Y
%
180.5%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.28%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.15%
0%
20.15%
6 Months
15.75%
0%
15.75%
1 Year
-10.17%
0.65%
-9.52%
2 Years
-7.3%
0.66%
-6.64%
3 Years
0%
1.95%
1.95%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 10.7 per share ex-dividend date: Sep-03-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Underperformer

Concord Biotech Ltd has been in the Third and Fourth Quartile in the YTD and longer periods

2
Quartile
quartile-2
QTD
10.97%
3
Quartile
quartile-3
Mar-Jun
26.49%
4
Quartile
quartile-4
Dec-Mar
-24.49%
3
Quartile
quartile-3
YTD
-11.22%
4
Quartile
quartile-4
2025
-39.12%
4
Quartile
quartile-4
2024
50.34%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Concord Biotech Ltd has not been a consistent performer in the YTD and longer periods

1
Quartile
quartile-1
QTD
10.97%
2
Quartile
quartile-2
Mar-Jun
26.49%
3
Quartile
quartile-3
Dec-Mar
-24.49%
3
Quartile
quartile-3
YTD
-11.22%
4
Quartile
quartile-4
2025
-39.12%
2
Quartile
quartile-2
2024
50.34%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Concord Biotech Ltd has not been a consistent performer in the YTD and longer periods

1
Quartile
quartile-1
QTD
10.97%
2
Quartile
quartile-2
Mar-Jun
26.49%
3
Quartile
quartile-3
Dec-Mar
-24.49%
3
Quartile
quartile-3
YTD
-11.22%
4
Quartile
quartile-4
2025
-39.12%
2
Quartile
quartile-2
2024
50.34%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available